Stocks in play: Satellos Bioscience Inc.
Announced a presentation of data at the 29th Annual Congress of the World Muscle Society taking place October 8-12 in Prague. The presentation will provide an overview of key data collected during the open-label pilot study of SAT-3247 in a canine model of Duchenne muscular dystrophy. Satellos Bioscience Inc. shares T.MSCL are trading up $0.03 at $0.49.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.